Status:
COMPLETED
B-TURP vs BipolEP in Management of BPH Patients With Medium-sized Prostates
Lead Sponsor:
Assiut University
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
45-80 years
Phase:
NA
Brief Summary
This is a comparative study of the efficacy and safety of endoscopic bipolar transurethral resection and enucleation of the prostate in management of benign prostatic hyperplasia patients with medium-...
Detailed Description
Benign prostatic hyperplasia (BPH) is a highly prevalent condition among aging males, with incidence rates escalating progressively with age. Epidemiological data indicate that approximately 8% of men...
Eligibility Criteria
Inclusion
- Male patients aged 45-80 years with symptomatic BPH (IPSS ≥8).
- Prostate volume between 40-80 cc as determined by transrectal ultrasound (TRUS).
- Failure of medical management.
- Written informed consent.
Exclusion
- Prostate cancer (suspected on PSA/DRE or confirmed by biopsy).
- Previous prostate/urethral surgery.
- Neurogenic bladder or urethral strictures.
- Significant coagulopathy.
- Uncontrolled urinary tract infection.
- Patient on anticoagulant medication.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT06939062
Start Date
July 1 2022
End Date
July 1 2025
Last Update
July 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Urology Hospital
Asyut, Egypt